全文获取类型
收费全文 | 3515篇 |
免费 | 312篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 122篇 |
妇产科学 | 65篇 |
基础医学 | 430篇 |
口腔科学 | 73篇 |
临床医学 | 373篇 |
内科学 | 707篇 |
皮肤病学 | 52篇 |
神经病学 | 194篇 |
特种医学 | 511篇 |
外科学 | 342篇 |
综合类 | 80篇 |
一般理论 | 3篇 |
预防医学 | 271篇 |
眼科学 | 131篇 |
药学 | 246篇 |
1篇 | |
中国医学 | 2篇 |
肿瘤学 | 202篇 |
出版年
2022年 | 21篇 |
2021年 | 27篇 |
2020年 | 19篇 |
2019年 | 34篇 |
2018年 | 55篇 |
2017年 | 34篇 |
2016年 | 31篇 |
2015年 | 50篇 |
2014年 | 67篇 |
2013年 | 88篇 |
2012年 | 88篇 |
2011年 | 132篇 |
2010年 | 84篇 |
2009年 | 113篇 |
2008年 | 119篇 |
2007年 | 135篇 |
2006年 | 143篇 |
2005年 | 119篇 |
2004年 | 126篇 |
2003年 | 107篇 |
2002年 | 104篇 |
2001年 | 79篇 |
2000年 | 86篇 |
1999年 | 69篇 |
1998年 | 98篇 |
1997年 | 97篇 |
1996年 | 95篇 |
1995年 | 80篇 |
1994年 | 53篇 |
1993年 | 70篇 |
1992年 | 71篇 |
1991年 | 77篇 |
1990年 | 78篇 |
1989年 | 121篇 |
1988年 | 95篇 |
1987年 | 106篇 |
1986年 | 95篇 |
1985年 | 108篇 |
1984年 | 70篇 |
1983年 | 63篇 |
1982年 | 45篇 |
1981年 | 52篇 |
1980年 | 52篇 |
1979年 | 35篇 |
1978年 | 44篇 |
1977年 | 38篇 |
1976年 | 34篇 |
1975年 | 33篇 |
1974年 | 17篇 |
1973年 | 21篇 |
排序方式: 共有3835条查询结果,搜索用时 15 毫秒
1.
Isolated patellofemoral arthritis is an increasingly recognized entity, and is usually associated with previous patellofemoral dysplasia or instability. Patellofemoral arthroplasty (PFA) has evolved significantly in recent years, both in terms of implant design and importantly in the understanding of appropriate patient selection. This review outlines the indications and investigations for PFA, provides a brief history of the development of contemporary implants, and presents the clinical outcomes for the prostheses most commonly used in the UK. In addition, it provides a detailed surgical technique for implantation of an onlay implant, with tips on how to optimize patellofemoral biomechanics and thus achieve a consistently good outcome. 相似文献
2.
3.
Bill J Gurley Ashley Swain Gary W Barone D Keith Williams Philip Breen C Ryan Yates Leslie B Stuart Martha A Hubbard Yudong Tong Sreekhar Cheboyina 《Drug metabolism and disposition》2007,35(2):240-245
Phytochemical-mediated modulation of P-glycoprotein (P-gp) and other drug transporters may give rise to many herb-drug interactions. Serial plasma concentration-time profiles of the P-gp substrate, digoxin, were used to determine whether supplementation with goldenseal or kava kava modified P-gp activity in vivo. Twenty healthy volunteers were randomly assigned to receive a standardized goldenseal (3210 mg daily) or kava kava (1227 mg daily) supplement for 14 days, followed by a 30-day washout period. Subjects were also randomized to receive rifampin (600 mg daily, 7 days) and clarithromycin (1000 mg daily, 7 days) as positive controls for P-gp induction and inhibition, respectively. Digoxin (Lanoxin, 0.5 mg) was administered p.o. before and at the end of each supplementation and control period. Serial digoxin plasma concentrations were obtained over 24 h and analyzed by chemiluminescent immunoassay. Comparisons of area under the curve (AUC)((0-3)), AUC((0-24)), C(max,) CL/F, and elimination half-life were used to assess the effects of goldenseal, kava kava, rifampin, and clarithromycin on digoxin pharmacokinetics. Rifampin produced significant reductions (p < 0.01) in AUC((0-3)), AUC((0-24)), CL/F, t(1/2), and C(max), whereas clarithromycin increased these parameters significantly (p < 0.01). With the exception of goldenseal's effect on C(max) (14% increase), no statistically significant effects on digoxin pharmacokinetics were observed following supplementation with either goldenseal or kava kava. When compared with rifampin and clarithromycin, supplementation with these specific formulations of goldenseal or kava kava did not appear to affect digoxin pharmacokinetics, suggesting that these supplements are not potent modulators of P-gp in vivo. 相似文献
4.
Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome 总被引:5,自引:0,他引:5
E Shapiro A K Shapiro G Fulop M Hubbard J Mandeli J Nordlie R A Phillips 《Archives of general psychiatry》1989,46(8):722-730
The results of this controlled study of the treatment of 57 patients with Gilles de la Tourette's syndrome suggested that both haloperidol and pimozide were more effective than placebo, but that haloperidol was slightly more effective than pimozide. Adverse effects occurred more frequently with haloperidol vs placebo than with pimozide vs placebo, but the frequency was not significantly different for haloperidol compared with pimozide. Clinically significant cardiac effects did not occur at a maximum dosage of 0.3 mg/kg or 20 mg/d for pimozide and 10 mg/d for haloperidol. However, the QTc interval was prolonged during pimozide treatment compared with that during haloperidol treatment, although the values for both medications were not in an abnormal range. 相似文献
5.
6.
7.
RA O. Hempel 《Notfall & Rettungsmedizin》2007,10(5):367-371
Legal uncertainties for emergency vehicle drivers can be avoided when fundamental rules are established. In particular, differentiation of special rights and rights of way is essential. Inherent in both is the urgency necessary to save human lives. The right of way signaled by flashing blue lights and siren does not however justify traffic violations but signifies rather a request to other traffic participants. In contrast, special rights require no announcement and constitute a justifiable reason for traffic violations. Even so they do not allow that other traffic participants be endangered or harmed. Adherence to these basic principles can prevent legal misinterpretations as well as rigid adoption of inflexible standards of behavior. 相似文献
8.
RA Mag. Dr. C. Gepart 《Notfall & Rettungsmedizin》2007,10(4):289-292
Austria’s new Living Wills Act (Patientenverfügungsgesetz, or PatVG) that came into effect on 1st of June 2006, is the first law in Austria to regulate the controversial issue of living wills. The PatVG provides for a right to refuse future medical treatment by making an advance directive in the form of a living will that is either binding or “to be taken into consideration”. However, the establishment of a binding living will is governed by strict criteria as regards form and content, and both a medical doctor and a legal expert must be involved. Compliance with a living will is not allowed where there is a legal obligation to give medical treatment. There is also a legal obligation to give medical treatment in emergency situations where the time involved in looking for a living will could seriously endanger the health or the life of a patient. 相似文献
9.
10.
Ohne Zusammenfassung 相似文献